Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 4/2017

01-04-2017 | Original Article

Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey

Authors: Rebecca Chambers, Adam Lucht, Aisling Reihill, Judith Hough

Published in: International Urogynecology Journal | Issue 4/2017

Login to get access

Abstract

Introduction and Hypothesis

Pelvic floor (PF) dysfunction in patients with cystic fibrosis (CF) is poorly understood due to lack of research. The aim of this study was to examine the prevalence, risk factors and bothersomeness of PF dysfunction and its implications for the clinical management of CF.

Methods

Of 64 adults with CF approached at a tertiary hospital, 60 were surveyed. A clinically meaningful score on the Australian Pelvic Floor Questionnaire (APFQ) is ≥1 in each of the bladder, bowel, sexual function and prolapse sections or a global PF score of ≥3. A frequency Likert scale was used to analyse the impact of PF dysfunction on the ability to perform physiotherapy lung management when well and unwell.

Results

The prevalence of clinically meaningful bladder dysfunction was 39 % in women and 12 % in men, the prevalence of bowel dysfunction was 54 % in women and 44 % in men, and the prevalence of sexual dysfunction was 43 % in women and 65 % in men. APFQ scores were clinically meaningful only for bowel dysfunction in women (median 1.47, IQR 0.59 – 2.28). PF dysfunction constrains lung management in up to 22 % of patients when well and in 37 % of patients when unwell.

Conclusions

PF dysfunction affects the adult CF population, with PF symptoms limiting the ability of up to one in three patients to participate in physiotherapy management.
Appendix
Available only for authorised users
Literature
1.
Baessler K, O’Neill S, Maher C, Battistutta D. Australian pelvic floor questionnaire: a validated interviewer-administered pelvic floor questionnaire for routine clinic and research. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(2):149–158.CrossRefPubMed
2.
MacLennan AH, Taylor AW, Wilson DH, Wilson D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. Br J Obstet Gynaecol. 2000;107(12):1460–1470.CrossRef
3.
Smith JA. Cough frequency and patterns of cough in cystic fibrosis. J R Soc Med. 2006;99 Suppl 46:17–22.PubMed
4.
5.
White D, Stiller K, Roney F. The prevalence and severity of symptoms of incontinence in adult cystic fibrosis patients. Physiother Theory Pract. 2000;16(1):35–42.CrossRef
6.
Dufeu N, Vitton V, Coltey B, Gomez C, Baumstark K, Bouvier M, et al. Fecal incontinence in adult CF patients: prevalence. J Cyst Fibros. 2013;12 Suppl 1:S112.CrossRef
7.
Henman S, Barker H, Haworth C, Floto A, Adler A, Lyons A, et al. Prevalence of erectile dysfunction in cystic fibrosis. J Cyst Fibros. 2010;9 Suppl 1:S103.CrossRef
8.
Wat D, Henman S, Barker H, Floto A, Adler A, Lyons A, et al. Aetiology of erectile dysfunction in cystic fibrosis. J Cyst Fibros. 2011;10 Suppl 1:S94.CrossRef
9.
Moran F, Bradley J, Boyle L, Elborn J. Incontinence in adult females with cystic fibrosis: a Northern Ireland survey. Int J Clin Pract. 2003;57(3):182–183.PubMed
10.
Gumery L, Lee J, Whitehouse J, Honeybourne D. The prevalence of urinary incontinence in adult cystic fibrosis males. J Cyst Fibros. 2005;4 Suppl 1:S97.
11.
12.
McIntosh L, Ridley S, Innes JA. Multi-centre questionnaire survey of the incidence, prevalence and severity of urinary stress incontinence in women with CF in Scotland. J Cyst Fibros. 2006;5 Suppl 1:S98.CrossRef
13.
Baessler K, O’Neill S, Maher C, Battistutta D. A validated self-administered female pelvic floor questionnaire. Int Urogynecol J Pelvic Floor Dysfunct. 2010;21(2):163–172.CrossRef
14.
Frankel SJ, Donovan JL, Peters TI, Abrams P, Dabhoiwala NF, Osawa D, et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol. 1998;51(8):677–685.CrossRefPubMed
15.
Donovan JL, Abrams P, Peters TJ, Kay HE, Reynard J, Chapple C, et al. The ICS-‘BPH’ study: the psychometric validity and reliability of the ICSmale questionnaire. BJU Int. 1996;77(4):554–562.CrossRef
16.
Donovan J, Kay H, Peters T, Abrams P, Coast J, Matos-Ferreira A, et al. Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-‘BPH’ study. BJU Int. 1997;80(5):712–721.CrossRef
17.
Likert R. A technique for the development of attitude scales. Educ Psychol Meas. 1952;12:313–315.CrossRef
18.
Quanjer P, Stanojevic S, Cole T, Baur X, Hall G, Culver B, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343.CrossRefPubMedPubMedCentral
19.
Thomas S, Stokes A, Angulatta V, Ketchell I, Duckers J. Stress urinary incontinence in adult CF patients: prevalence and physiotherapy management in Wales. J Cyst Fibros. 2012;11:S109.CrossRef
20.
Vella M, Cartwright R, Cardozo L, Parsons M, Madge S, Burns Y. Prevalence of incontinence and incontinence-specific quality of life impairment in women with cystic fibrosis. Neurourol Urodyn. 2009;28(8):986–989.CrossRefPubMed
21.
Hodges PW, Heijnen I, Gandevia SC. Postural activity of the diaphragm is reduced in humans when respiratory demand increases. J Physiol. 2001;537(Pt 3):999–1008.CrossRefPubMedPubMedCentral
22.
Staskin D, Tubaro A, Norton PA, Ashton-Miller JA. Mechanisms of continence and surgical cure in female and male SUI: surgical research initiatives. Neurourol Urodyn. 2011;30(5):704–707.CrossRefPubMed
23.
van der Doef H, Kokke F, Beek F, Woestenenk J, Froeling S, Houwen R. Constipation in pediatric cystic fibrosis patients: an underestimated medical condition. J Cyst Fibros. 2010;9(1):59–63.CrossRefPubMed
24.
Durnea C, Khashan A, Kenny L, Tabirca S, O’Reilly B. An insight into pelvic floor status in nulliparous women. Int Urogynecol J Pelvic Floor Dysfunct. 2014;25(3):337–345.CrossRef
25.
Longo L, Speri S, Sartori G, Doro R. Vaginal disorders in CF women: preliminary results of a nurse led study. J Cyst Fibros. 2002;1 Suppl 1:S172.
26.
Wilschanski M, Corey M, Durie P, Tullis E, Bain J, Asch M, et al. Diversity of reproductive tract abnormalities in men with cystic fibrosis. JAMA. 1996;276(8):607–608.CrossRefPubMed
27.
Button BM, Sherburn M, Chase J, McLachlan Z, Kotsimbos T, Wilson J. Urinary incontinence and bowel problems in women with CF and chronic obstructive pulmonary disease (COPD) compared with controls. J Cyst Fibros. 2004;3 Suppl 1:S94.
28.
Cornacchia M, Zenorini A, Perobelli S, Zanolla L, Mastella G, Braggion C. Prevalence of urinary incontinence in women with cystic fibrosis. BJU Int. 2001;88(1):44–48.CrossRefPubMed
29.
Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48(11):1531–1548.CrossRefPubMed
30.
The Thoracic Society of Australia and New Zealand. Physiotherapy for cystic fibrosis in Australia: a consensus statement. International Physiotherapy Group for Cystic Fibrosis, Australian Chapter. The Thoracic Society of Australia and New Zealand, Sydney, NSW. 2008.
Metadata
Title
Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey
Authors
Rebecca Chambers
Adam Lucht
Aisling Reihill
Judith Hough
Publication date
01-04-2017
Publisher
Springer London
Published in
International Urogynecology Journal / Issue 4/2017
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-016-3152-z

Other articles of this Issue 4/2017

International Urogynecology Journal 4/2017 Go to the issue

Letter to the Editor

Comment on the recently published IUGA/ICS joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction

Original Article

De novo stress urinary incontinence after pelvic organ prolapse surgery in women without occult incontinence

Original Article

Patient satisfaction and regret with decision differ between outcomes in the composite definition of success after reconstructive surgery

Original Article

Outcome of coexistent overactive bladder symptoms in women with urodynamic urinary incontinence following anti-incontinence surgery

Original Article

Barriers to seeking care for accidental bowel leakage: a qualitative study

Special Contribution

Female genital mutilation: the role of medical professional organizations